|
1
|
Norman RJ, Dewailly D, Legro RS and Hickey
TE: Polycystic ovary syndrome. Lancet. 370:685–697. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lizneva D, Suturina L, Walker W, Brakta S,
Gavrilova-Jordan L and Azziz R: Criteria, prevalence, and
phenotypes of polycystic ovary syndrome. Fertil Steril. 106:6–15.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Moran LJ, Misso ML, Wild RA and Norman RJ:
Impaired glucose tolerance, type 2 diabetes and metabolic syndrome
in polycystic ovary syndrome: A systematic review and
meta-analysis. Hum Reprod Update. 16:347–363. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Diamanti-Kandarakis E and Dunaif A:
Insulin resistance and the polycystic ovary syndrome revisited: An
update on mechanisms and implications. Endocr Rev. 33:981–1030.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Badawy A and Elnashar A: Treatment options
for polycystic ovary syndrome. Int J Womens Health. 3:25–35. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Toulis KA, Goulis DG, Farmakiotis D,
Georgopoulos NA, Katsikis I, Tarlatzis BC, Papadimas I and Panidis
D: Adiponectin levels in women with polycystic ovary syndrome: A
systematic review and a meta-analysis. Hum Reprod Update.
15:297–307. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Telli MH, Yildirim M and Noyan V: Serum
leptin levels in patients with polycystic ovary syndrome. Fertil
Steril. 77:932–935. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li M, Yang M, Zhou X, Fang X, Hu W, Zhu W,
Wang C, Liu D, Li S, Liu H, et al: Elevated circulating levels of
irisin and the effect of metformin treatment in women with
polycystic ovary syndrome. J Clin Endocrinol Metab. 100:1485–1493.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lynch CJ and Adams SH: Branched-chain
amino acids in metabolic signalling and insulin resistance. Nat Rev
Endocrinol. 10:723–736. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Meigs JB, Jacques PF, Selhub J, Singer DE,
Nathan DM, Rifai N, D'Agostino RB Sr and Wilson PW: Framingham
Offspring Study: Fasting plasma homocysteine levels in the insulin
resistance syndrome: The Framingham offspring study. Diabetes Care.
24:1403–1410. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Buysschaert M, Dramais AS, Wallemacq PE
and Hermans MP: Hyperhomocysteinemia in type 2 diabetes:
Relationship to macroangiopathy, nephropathy, and insulin
resistance. Diabetes Care. 23:1816–1822. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Selhub J: Homocysteine metabolism. Annu
Rev Nutr. 19:217–246. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Finkelstein JD: The metabolism of
homocysteine: Pathways and regulation. Eur J Pediatr. 157 Suppl
2:S40–S44. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chiang EPI, Wang YC, Chen WW and Tang FY:
Effects of insulin and glucose on cellular metabolic fluxes in
homocysteine transsulfuration, remethylation, S-adenosylmethionine
synthesis, and global deoxyribonucleic acid methylation. J Clin
Endocrinol Metab. 94:1017–1025. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lievers KJ, Boers GH, Verhoef P, den
Heijer M, Kluijtmans LA, van der Put NM, Trijbels FJ and Blom HJ: A
second common variant in the methylenetetrahydrofolate reductase
(MTHFR) gene and its relationship to MTHFR enzyme activity,
homocysteine, and cardiovascular disease risk. J Mol Med (Berl).
79:522–528. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liew SC and Gupta ED:
Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism:
Epidemiology, metabolism and the associated diseases. Eur J Med
Genet. 58:1–10. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Grodnitskaya EE and Kurtser MA:
Homocysteine metabolism in polycystic ovary syndrome. Gynecol
Endocrinol. 28:186–189. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Salehpour S, Manzor-Al-Ajdad O, Samani EN
and Abadi A: Evaluation of homocysteine levels in patients with
polycystic ovarian syndrome. Int J Fertil Steril. 4:168–171.
2011.PubMed/NCBI
|
|
19
|
Orio F Jr, Palomba S, Di Biase S, Colao A,
Tauchmanova L, Savastano S, Labella D, Russo T, Zullo F and
Lombardi G: Homocysteine levels and C677T polymorphism of
methylenetetrahydrofolate reductase in women with polycystic ovary
syndrome. J Clin Endocrinol Metab. 88:673–679. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Alfaqih MA, Khader YS, Al-Dwairi AN,
Alzoubi A, Al-Shboul O and Hatim A: Lower Levels of Serum
Adiponectin and the T Allele of rs1501299 of the ADIPOQ Gene Are
Protective against Polycystic Ovarian Syndrome in Jordan. Korean J
Fam Med. 39:108–113. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rotterdam ESHRE/ASRM-Sponsored PCOS
consensus workshop group, . Revised 2003 consensus on diagnostic
criteria and long-term health risks related to polycystic ovary
syndrome (PCOS). Hum Reprod. 19:41–47. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Faul F, Erdfelder E, Lang A-G and Buchner
A: G*Power 3: A flexible statistical power analysis program for the
social, behavioral, and biomedical sciences. Behav Res Methods.
39:175–191. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chongsuvivatwong V: Analysis of
epidemiological data using R and Epicalc. Epidemiology Unit, Prince
of Songkla University; Thailand: pp. 3282008
|
|
24
|
Brown KS, Kluijtmans LAJ, Young IS, Murray
L, McMaster D, Woodside JV, Yarnell JW, Boreham CA, McNulty H,
Strain JJ, et al: The 5,10-methylenetetrahydrofolate reductase
C677T polymorphism interacts with smoking to increase homocysteine.
Atherosclerosis. 174:315–322. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Diamanti-Kandarakis E and Christakou CD:
Insulin resistance in PCOSDiagnosis and Management of Polycystic
Ovary Syndrome. Springer; New York, NY: pp. 35–61. 2009
|
|
26
|
Padmanabhan V and Veiga-Lopez A: Animal
models of the polycystic ovary syndrome phenotype. Steroids.
78:734–740. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Toole JF, Malinow MR, Chambless LE, Spence
JD, Pettigrew LC, Howard VJ, Sides EG, Wang CH and Stampfer M:
Lowering homocysteine in patients with ischemic stroke to prevent
recurrent stroke, myocardial infarction, and death: The Vitamin
Intervention for Stroke Prevention (VISP) randomized controlled
trial. JAMA. 291:565–575. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Toulis KA, Goulis DG, Mintziori G,
Kintiraki E, Eukarpidis E, Mouratoglou SA, Pavlaki A, Stergianos S,
Poulasouchidou M, Tzellos TG, et al: Meta-analysis of
cardiovascular disease risk markers in women with polycystic ovary
syndrome. Hum Reprod Update. 17:741–760. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Moustapha A, Naso A, Nahlawi M, Gupta A,
Arheart KL, Jacobsen DW, Robinson K and Dennis VW: Prospective
study of hyperhomocysteinemia as an adverse cardiovascular risk
factor in end-stage renal disease. Circulation. 97:138–141. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wald DS, Law M and Morris JK: Homocysteine
and cardiovascular disease: Evidence on causality from a
meta-analysis. BMJ. 325:1202–1206. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Brattström L and Wilcken DE: Homocysteine
and cardiovascular disease: Cause or effect? Am J Clin Nutr.
72:315–323. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wijeyaratne CN, Seneviratne RA, Dahanayake
S, Kumarapeli V, Palipane E, Kuruppu N, Yapa C, Seneviratne RA and
Balen AH: Phenotype and metabolic profile of South Asian women with
polycystic ovary syndrome (PCOS): Results of a large database from
a specialist Endocrine Clinic. Hum Reprod. 26:202–213. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Dunaif A, Sorbara L, Delson R and Green G:
Ethnicity and polycystic ovary syndrome are associated with
independent and additive decreases in insulin action in
Caribbean-Hispanic women. Diabetes. 42:1462–1468. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Meng Y, Chen X, Peng Z, Liu X, Sun Y and
Dai S: Association between high serum homocysteine levels and
biochemical characteristics in women with polycystic ovarian
syndrome: A systematic review and meta-analysis. PLoS One.
11:e01573892016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhao Y and Qiao J: Ethnic differences in
the phenotypic expression of polycystic ovary syndrome. Steroids.
78:755–760. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gibson-Helm M, Teede H, Dunaif A and
Dokras A: Delayed diagnosis and a lack of information associated
with dissatisfaction in women with polycystic ovary syndrome. J
Clin Endocrinol Metab. 102:604–612. 2017.PubMed/NCBI
|
|
37
|
Cree-Green M: Worldwide dissatisfaction
with the diagnostic process and initial treatment of PCOS. J Clin
Endocrinol Metab. 102:375–378. 2017.PubMed/NCBI
|
|
38
|
Fulghesu AM, Porru C and Canu E: Diagnosis
of Polycystic Ovarian Syndrome in AdolescenceGood Practice in
Pediatric and Adolescent Gynecology. Springer; pp. 143–159. 2018,
View Article : Google Scholar
|
|
39
|
Boyle JA and Teede HJ: PCOS: Refining
diagnostic features in PCOS to optimize health outcomes. Nat Rev
Endocrinol. 12:630–631. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Cammisotto PG and Bendayan M: Leptin
secretion by white adipose tissue and gastric mucosa. Histol
Histopathol. 22:199–210. 2007.PubMed/NCBI
|
|
41
|
Klok MD, Jakobsdottir S and Drent ML: The
role of leptin and ghrelin in the regulation of food intake and
body weight in humans: A review. Obes Rev. 8:21–34. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Houjeghani S, Gargari Pourghassem B and
Farzadi L: Serum leptin and ghrelin levels in women with polycystic
ovary syndrome: Correlation with anthropometric, metabolic, and
endocrine parameters. Int J Fertil Steril. 6:117–126.
2012.PubMed/NCBI
|
